Skip to main content

FDA recall, , Moderate risk

Apollo Care Semaglutide Injection Vials

Semaglutide sterile multi-dose vials contain particulate matter identified as nylon/polyamide and silk/proteinaceous-type material.

What happened

Apollo Care, LLC of Columbia, Missouri recalled multiple Semaglutide sterile multi-dose vials because they contain particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The FDA listed the products in its Enforcement Report on August 7, 2026, and the recall began July 29, 2026. The products were distributed nationwide within the U.S.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match your product and all the details in one listed combination.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Semaglutide

    1. Strength
      7.5 mg
      NDC
      • 71170-721-01
      Lot code
      • AC-017273
    2. Strength
      12.5 mg
      NDC
      • 71170-495-05
      Lot code
      • AC-017108
    3. Strength
      2.5 mg
      NDC
      • 71170-711-02
      Lot code
      • AC-017271
    4. Strength
      2.25 mg
      NDC
      • 71170-811-02
      Lot code
      • AC-017114
    5. Strength
      0.9 mg
      NDC
      • 71170-810-01
      Lot code
      • AC-017131
    6. Strength
      6.75 mg
      NDC
      • 71170-821-01
      Lot code
      • C-017115
    7. Strength
      9 mg
      NDC
      • 71170-822-02
      Lot code
      • AC-017125
    8. Strength
      10 mg
      NDC
      • 71170-722-02
      Lot code
      • AC-017274
    9. Strength
      20 mg
      NDC
      • 71170-724-04
      Lot code
      • AC-017275
    10. Strength
      4.5 mg
      NDC
      • 71170-812-03
      Lot code
      • AC-017124
    11. Strength
      5 mg
      NDC
      • 71170-712-03
      Lot code
      • AC-017272

Recall details

Company began the recall
Sold in

Nationwide within the U.S

Company
Apollo Care, LLCColumbia, Missouri
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99505
Recall numbers
D-0747-2026 to D-0757-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)